首页|Action mechanism of Yiqi Hexue Formula in the treatment of liver cirrhosis based on network pharmacology and experimental verification

Action mechanism of Yiqi Hexue Formula in the treatment of liver cirrhosis based on network pharmacology and experimental verification

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
  • 维普
Objective: To study the mechanism of Yiqi Hexue Formula in the treatment of liver cirrhosis based on network pharmacology and experimental verification. Methods: Firstly, the effective components and action targets of various traditional Chinese medicines in Yiqi Hexue Formula were searched from TCMSP and BATMAN-TCM databases. The disease target genes were obtained by using GeneCard, PharmGkb, OMIM, DrugBank and TTD databases. The potential target genes of drugs and disease target genes were intersected, and the Venn diagram was drawn.The "active ingredient-core target" network was constructed by Cytoscape software, and the KEGG pathway of the intersection genes was analyzed by R software. Animal experiments were conducted to observe the effect of Yiqi Hexue Formula on histopathology of CCl4-induced liver cirrhosis model rats, determine the expression levels of JAK2 and STAT3 mRNA in liver tissue, and preliminarily explore the mechanism of Yiqi Hexue Formula in the treatment of liver cirrhosis. Results: A total of 43 active components and 648 targets of Yiqi Hexue Formula for the treatment of liver cirrhosis were screened through the database. KEGG pathway analysis showed that Yiqi Hexue Formula mainly affected PI3K/Akt, MAPK, IL-17 and JAK/STAT signaling pathway. Animal experimental research showed that compared with the model group, the degree of inflammation and fibrosis in liver tissue of rats treated with Yiqi Hexue Formula was significantly improved; The expression of JAK2 and STAT3 mRNA decreased significantly in the treatment group of Yiqi Hexue Formula (P<0.05).Conclusion: Yiqi Hexue Formula can treat liver cirrhosis through multiple components, multiple targets and multiple pathways. JAK2/STAT3 signaling pathway is involved in the formation of liver cirrhosis. Yiqi Hexue Formula can improve the pathological manifestations of cirrhotic rats. Its mechanism may be related to inhibiting the transmission of JAK2/STAT3 signaling pathway.

Yiqi Hexue FormulaLiver cirrhosisNetwork pharmacologyMechanism of action

ZHANG Ying-xue、SUN Feng-xia、LI Xiao-ling、XU Chun-jun、GUO Yu-fei、CHEN Zimeng

展开 >

Beijing University of Chinese Medicine,Beijing 100029,China

Department of Infections,Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University,Beijing 100010,China

Capital Health Development Research ProjectSpecial Research Project on Business Construction of National Clinical Research Base of Traditional Chinese Medicine of Administ

2018-2-2173JDZX2015182

2022

海南医科大学学报(英文版)

海南医科大学学报(英文版)

ISSN：
年,卷(期)：2022.28(18)
  • 12